2.37
price down icon4.44%   -0.11
after-market Dopo l'orario di chiusura: 2.43 0.06 +2.53%
loading

C 4 Therapeutics Inc Azioni (CCCC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
10.71%
6.463
7.238 15.36 12.01 3.039
Operating Expenses
3.95%
34.96
36.40 43.61 33.45 35.26
Benefits Costs and Expenses
3.21%
32.48
33.56 40.03 29.72 31.40
Costs And Expenses
3.21%
32.48
33.56 40.03 29.72 31.40
Operating Income/Loss
2.27%
-28.50
-29.16 -28.24 -21.44 -32.22
Nonoperating Income/Loss
12.70%
2.481
2.842 3.578 3.726 3.858
Income/Loss From Continuing Operations Before Tax
1.15%
-26.02
-26.32 -24.67 -17.72 -28.36
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
1.15%
-26.02
-26.32 -24.67 -17.72 -28.36
Net Income/Loss
1.15%
-26.02
-26.32 -24.67 -17.72 -28.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.24%
71.01
70.83 69.63 68.81 68.43
Diluted Average Shares
0.24%
71.01
70.83 69.63 68.81 68.43
Basic Earnings Per Share
0.00%
-0.37
-0.37 -0.35 -0.26 -0.41
Diluted Earnings Per Share
0.00%
-0.37
-0.37 -0.35 -0.26 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):